LFCM

Long Focus Capital Management Portfolio holdings

AUM $1.55B
1-Year Return 20.57%
This Quarter Return
+5.18%
1 Year Return
+20.57%
3 Year Return
+43.45%
5 Year Return
10 Year Return
AUM
$467M
AUM Growth
+$100M
Cap. Flow
+$64.8M
Cap. Flow %
13.86%
Top 10 Hldgs %
40.66%
Holding
112
New
13
Increased
37
Reduced
11
Closed
11

Sector Composition

1 Energy 21.85%
2 Financials 19%
3 Communication Services 12.34%
4 Healthcare 10.91%
5 Technology 9.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BLCM
76
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$518K 0.07%
+239,762
New +$518K
TE
77
T1 Energy Inc.
TE
$293M
$490K 0.06%
40,000
BOXL icon
78
Boxlight
BOXL
$4.49M
$480K 0.06%
10,000
+2,500
+33% +$120K
IRIX icon
79
IRIDEX
IRIX
$22.9M
$463K 0.06%
100,000
MBI icon
80
MBIA
MBI
$401M
$462K 0.06%
30,000
ACHV icon
81
Achieve Life Sciences
ACHV
$141M
$454K 0.06%
60,000
GM icon
82
General Motors
GM
$55.8B
$437K 0.06%
10,000
LVS icon
83
Las Vegas Sands
LVS
$37.8B
$389K 0.05%
+10,000
New +$389K
LCTX icon
84
Lineage Cell Therapeutics
LCTX
$279M
$331K 0.04%
215,000
ANIX icon
85
Anixa Biosciences
ANIX
$95.7M
$317K 0.04%
115,701
+94,404
+443% +$259K
DISH
86
DELISTED
DISH Network Corp.
DISH
$317K 0.04%
10,000
TUSK icon
87
Mammoth Energy Services
TUSK
$113M
$261K 0.03%
122,681
MODG icon
88
Topgolf Callaway Brands
MODG
$1.71B
$234K 0.03%
+10,000
New +$234K
CDXS icon
89
Codexis
CDXS
$226M
$206K 0.03%
10,000
PSFE icon
90
Paysafe
PSFE
$859M
$170K 0.02%
4,167
-12,500
-75% -$510K
IGICW
91
DELISTED
International General Insurance Holdings Ltd. Warrants expiring 03/17/2025
IGICW
$165K 0.02%
220,005
CRKN
92
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
-$356K
MBII
93
DELISTED
Marrone Bio Innovations, Inc.
MBII
$108K 0.01%
100,000
AMBC icon
94
Ambac
AMBC
$425M
$104K 0.01%
10,000
BIVI icon
95
BioVie
BIVI
$12.2M
$94K 0.01%
200
ONCS
96
DELISTED
OncoSec Medical Incorporated
ONCS
$80K 0.01%
3,147
ONCY
97
Oncolytics Biotech
ONCY
$109M
$63K 0.01%
40,000
AAPL icon
98
Apple
AAPL
$3.56T
-10,000
Closed -$1.78M
ABBV icon
99
AbbVie
ABBV
$378B
0
BMY icon
100
Bristol-Myers Squibb
BMY
$95.4B
0